Incidental Mutation 'R4177:Bscl2'
ID 319576
Institutional Source Beutler Lab
Gene Symbol Bscl2
Ensembl Gene ENSMUSG00000071657
Gene Name BSCL2 lipid droplet biogenesis associated, seipin
Synonyms seipin, Gng3lg
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R4177 (G1)
Quality Score 225
Status Validated
Chromosome 19
Chromosomal Location 8814831-8826047 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 8817120 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Aspartic acid to Glycine at position 16 (D16G)
Ref Sequence ENSEMBL: ENSMUSP00000125250 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000086058] [ENSMUST00000096259] [ENSMUST00000159634] [ENSMUST00000160556] [ENSMUST00000160897] [ENSMUST00000171649]
AlphaFold Q9Z2E9
Predicted Effect probably benign
Transcript: ENSMUST00000086058
SMART Domains Protein: ENSMUSP00000083224
Gene: ENSMUSG00000071657

DomainStartEndE-ValueType
Pfam:Seipin 37 243 3.9e-71 PFAM
Blast:PAC 269 306 4e-7 BLAST
low complexity region 353 371 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000096259
SMART Domains Protein: ENSMUSP00000093978
Gene: ENSMUSG00000071658

DomainStartEndE-ValueType
G_gamma 9 75 1.21e-24 SMART
GGL 13 75 1.68e-31 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000159571
Predicted Effect probably benign
Transcript: ENSMUST00000159634
SMART Domains Protein: ENSMUSP00000125422
Gene: ENSMUSG00000071657

DomainStartEndE-ValueType
Pfam:Seipin 37 243 3.9e-71 PFAM
Blast:PAC 269 306 4e-7 BLAST
low complexity region 353 371 N/A INTRINSIC
Predicted Effect noncoding transcript
Transcript: ENSMUST00000159770
Predicted Effect probably benign
Transcript: ENSMUST00000160556
SMART Domains Protein: ENSMUSP00000123976
Gene: ENSMUSG00000071657

DomainStartEndE-ValueType
Pfam:Seipin 37 243 3.9e-71 PFAM
Blast:PAC 269 306 4e-7 BLAST
low complexity region 353 371 N/A INTRINSIC
Predicted Effect possibly damaging
Transcript: ENSMUST00000160897
AA Change: D16G

PolyPhen 2 Score 0.845 (Sensitivity: 0.83; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000125250
Gene: ENSMUSG00000071657
AA Change: D16G

DomainStartEndE-ValueType
Pfam:Seipin 97 208 2.8e-34 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000171649
AA Change: D16G

PolyPhen 2 Score 0.428 (Sensitivity: 0.89; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000127685
Gene: ENSMUSG00000071657
AA Change: D16G

DomainStartEndE-ValueType
Pfam:Seipin 99 302 8.5e-66 PFAM
Blast:PAC 329 366 2e-6 BLAST
low complexity region 413 431 N/A INTRINSIC
Predicted Effect noncoding transcript
Transcript: ENSMUST00000162580
Predicted Effect noncoding transcript
Transcript: ENSMUST00000162071
Meta Mutation Damage Score 0.1284 question?
Coding Region Coverage
  • 1x: 99.2%
  • 3x: 98.6%
  • 10x: 97.3%
  • 20x: 95.2%
Validation Efficiency 100% (46/46)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes the multi-pass transmembrane protein protein seipin. This protein localizes to the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Naturally occurring read-through transcription occurs between this locus and the neighboring locus HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2).[provided by RefSeq, Mar 2011]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit severe generalized lipodystrophy with hepatic steatosis, glucose intolerance, and insulin resistance. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 37 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Aicda A T 6: 122,538,043 (GRCm39) D67V probably benign Het
Arhgap32 A G 9: 32,158,510 (GRCm39) R182G probably null Het
Bbx T C 16: 50,045,221 (GRCm39) K447E probably damaging Het
Celsr2 A G 3: 108,321,294 (GRCm39) V506A probably damaging Het
Cenpf T A 1: 189,400,816 (GRCm39) Q441L possibly damaging Het
Crebbp A T 16: 3,937,663 (GRCm39) M700K possibly damaging Het
Dhcr7 A G 7: 143,394,910 (GRCm39) Y142C probably damaging Het
Dnajc2 A G 5: 21,962,394 (GRCm39) M602T probably benign Het
Dysf C T 6: 84,044,013 (GRCm39) R254* probably null Het
Ednra A C 8: 78,401,677 (GRCm39) I204M possibly damaging Het
Fabp2 A G 3: 122,690,547 (GRCm39) T77A possibly damaging Het
Gm10322 C A 10: 59,452,052 (GRCm39) N56K probably benign Het
Gnb1 T C 4: 155,625,113 (GRCm39) probably benign Het
Gpc2 T C 5: 138,275,621 (GRCm39) probably benign Het
Kmt2a T C 9: 44,732,280 (GRCm39) probably benign Het
Lypla2 T C 4: 135,696,403 (GRCm39) probably benign Het
Maf A T 8: 116,433,210 (GRCm39) Y131* probably null Het
Mfsd4a T A 1: 131,968,295 (GRCm39) H335L probably damaging Het
Mrgpra9 A G 7: 46,885,302 (GRCm39) Y122H probably damaging Het
Myo10 A T 15: 25,734,137 (GRCm39) Q342L possibly damaging Het
N4bp2 A G 5: 65,955,513 (GRCm39) probably null Het
Or5t15 A T 2: 86,681,745 (GRCm39) M99K possibly damaging Het
Pomt1 A G 2: 32,138,689 (GRCm39) N435S probably damaging Het
Pram1 A G 17: 33,860,203 (GRCm39) I257V probably benign Het
Rab9 G T X: 165,241,296 (GRCm39) S5* probably null Het
Ralgapa2 A T 2: 146,327,083 (GRCm39) Y59N probably damaging Het
Rasgrf2 C T 13: 92,038,717 (GRCm39) G1043D probably damaging Het
Rps6kc1 G A 1: 190,532,616 (GRCm39) T462M possibly damaging Het
Selenoo C T 15: 88,983,662 (GRCm39) probably benign Het
Sptb G C 12: 76,659,953 (GRCm39) D982E probably benign Het
Tab2 A G 10: 7,795,123 (GRCm39) V453A probably damaging Het
Ubald1 A G 16: 4,693,745 (GRCm39) probably benign Het
Ube2d1 T C 10: 71,094,033 (GRCm39) K101R probably damaging Het
Unc5cl A G 17: 48,769,298 (GRCm39) T261A probably benign Het
Zcwpw1 G T 5: 137,798,395 (GRCm39) K197N probably damaging Het
Zfp268 T C 4: 145,347,225 (GRCm39) L43S probably damaging Het
Zfyve19 A G 2: 119,046,693 (GRCm39) T296A possibly damaging Het
Other mutations in Bscl2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01908:Bscl2 APN 19 8,822,640 (GRCm39) missense probably damaging 0.99
IGL03206:Bscl2 APN 19 8,820,453 (GRCm39) missense probably damaging 0.97
R0193:Bscl2 UTSW 19 8,824,793 (GRCm39) missense probably benign 0.21
R1112:Bscl2 UTSW 19 8,817,098 (GRCm39) missense possibly damaging 0.90
R1513:Bscl2 UTSW 19 8,818,509 (GRCm39) missense probably damaging 1.00
R2049:Bscl2 UTSW 19 8,822,684 (GRCm39) splice site probably null
R2121:Bscl2 UTSW 19 8,817,146 (GRCm39) nonsense probably null
R2140:Bscl2 UTSW 19 8,822,684 (GRCm39) splice site probably null
R2142:Bscl2 UTSW 19 8,822,684 (GRCm39) splice site probably null
R2483:Bscl2 UTSW 19 8,818,514 (GRCm39) missense probably benign 0.01
R3623:Bscl2 UTSW 19 8,818,514 (GRCm39) missense probably benign 0.01
R4675:Bscl2 UTSW 19 8,825,523 (GRCm39) missense possibly damaging 0.81
R4967:Bscl2 UTSW 19 8,825,344 (GRCm39) missense probably benign 0.02
R5051:Bscl2 UTSW 19 8,822,643 (GRCm39) nonsense probably null
R5446:Bscl2 UTSW 19 8,823,564 (GRCm39) missense possibly damaging 0.91
R6493:Bscl2 UTSW 19 8,817,138 (GRCm39) missense probably damaging 1.00
R6838:Bscl2 UTSW 19 8,818,745 (GRCm39) missense probably damaging 1.00
R7117:Bscl2 UTSW 19 8,825,878 (GRCm39) missense possibly damaging 0.68
R7401:Bscl2 UTSW 19 8,823,914 (GRCm39) missense possibly damaging 0.57
R7923:Bscl2 UTSW 19 8,824,883 (GRCm39) missense probably benign 0.00
R8249:Bscl2 UTSW 19 8,823,884 (GRCm39) missense probably damaging 1.00
R8332:Bscl2 UTSW 19 8,823,594 (GRCm39) missense probably benign 0.23
R8748:Bscl2 UTSW 19 8,825,311 (GRCm39) missense probably damaging 0.99
R8870:Bscl2 UTSW 19 8,824,793 (GRCm39) missense probably benign 0.02
R8926:Bscl2 UTSW 19 8,825,348 (GRCm39) critical splice donor site probably null
R9249:Bscl2 UTSW 19 8,820,378 (GRCm39) missense probably damaging 1.00
R9691:Bscl2 UTSW 19 8,817,110 (GRCm39) missense probably benign
Predicted Primers PCR Primer
(F):5'- CACCGTTCTTCAGAGCTAGG -3'
(R):5'- GTGGCATCGTCTGGATAACGTC -3'

Sequencing Primer
(F):5'- CACCGTTCTTCAGAGCTAGGAAAATG -3'
(R):5'- GCAAGGCCAATGCACATCTTTTTG -3'
Posted On 2015-06-10